EGFR HER4

The payment platform does not support the transaction of prescription drugs. Retail customers can contact the customer service in the lower right corner to purchase. Pharmacies and hospitals can supply drugs at wholesale prices with photos of business premises under their business licenses.

Neratinib, as a single agent, is indicated for the extended adjuvant treatment of adult patients with early-stage HER2-positive breast cancer, as an adjunct to trastuzumab.

Sale

Neratinib, as a single agent, is indicated for the extended adjuvant treatment of adult patients with early-stage HER2-positive breast cancer, as an adjunct to trastuzumab.

Regular price ¥2,200.00 CNY

Regular price ~~¥3,600.00 CNY~~ Sale price ¥2,200.00 CNY
Unit price per

Sale

Item added to your cart

Collection: EGFR HER4

Neratinib, as a single agent, is indicated for the extended adjuvant treatment of adult patients with early-stage HER2-positive breast cancer, as an adjunct to trastuzumab.

Neratinib, as a single agent, is indicated for the extended adjuvant treatment of adult patients with early-stage HER2-positive breast cancer, as an adjunct to trastuzumab.

Country/region

Language